Jun 16 2015
Parallel 6, an innovator in enterprise mobile engagement and management solutions, and Sentrian™, the Remote Patient Intelligence™ company aspiring to eliminate all preventable hospitalization, announced today as technology partners, Clinical Reach’s ReachLink Connector will send patient data securely from the palm of the patient's hand to Sentrian’s remote patient monitoring platform (Sentrian RPI).
Parallel 6 will power Sentrian mobile applications to help care teams better engage with chronic disease patients, turning patient self-report data into another data input for the powerful Sentrian analytics engine.
Clinical Reach, a Parallel 6 product, enables clinical trial stakeholders to digitally recruit, eQualify, eConsent and engage clinical trial participants through their patented platform. (Photo: Business Wire)
Clinical Reach is a HIPAA compliant, end-to-end patient lifecycle management and engagement platform. Its ReachLink Connector’s ability to securely collect large amounts of patient data in real-time via mobile and send through to the Sentrian RPI platform will securely serve both patients and care teams in multiple languages around the world.
“As we combine our solution with Sentrian’s award winning RPI platform, our technology changes the way patients and healthcare providers evaluate their health,” said CEO of Parallel 6, Allan Camaisa. “Our technologies are empowering people all over the world to securely communicate.”
“We’re always seeking to provide our care teams and patients with the most effective interaction tools and platforms,” said Co-Founder, Chief Executive Officer of Sentrian, Dean Sawyer. “Together, we’re helping improve patient outcomes, reduce avoidable costs and improve patient satisfaction for those dealing with complex chronic disease.”
Parallel 6 is an exhibitor at the DIA 2015 51st Annual Meeting gathering in Washington, D.C., Booth #1957. Parallel 6 CEO and Chairman, Allan Camaisa, and President, CTO and Founder, David Turner, will be available for interviews and a demo of their technology platform. Please contact: Nikki Jimenez, [email protected], 619-233-7778, to schedule a briefing and/or interview.
About Parallel 6
Parallel 6, an innovator in enterprise cloud-based technologies, enables customer engagement and real-time data insights. Clinical Reach, a Parallel 6 product, enables clinical trial stakeholders to digitally recruit, eQualify, eConsent and engage clinical trial participants through their patented platform. Additional solutions include GovReach for Government Agencies and Captive Reach for corporate organizations which desire to communicate via push notifications, gamification strategies and more. The firm is headquartered in San Diego with Federal offices in Washington, D.C. For more information, visit http://www.parallel6.com/ @Parallel6
About Sentrian
Sentrian™, the first Remote Patient Intelligence™ company, aspires to eliminate all preventable hospitalization by leveraging the revolution in remote biosensors and machine learning to detect patient deterioration early, before it becomes acute. Sentrian’s value proposition to healthcare organizations is to provide a cloud-based remote patient monitoring and analytics platform intended to dramatically reduce preventable hospital admissions, increase the efficiency and effectiveness of care teams and improve quality metrics such as HEDIS and Star ratings. The Sentrian platform is designed to seamlessly integrate with existing healthcare information systems and clinical workflows, facilitating adoption. Find us at http://sentrian.com/, on Twitter and LinkedIn.